Provigate

Unlocking the power of behavior change

Tokyo, Japan · $16.7M raised

Headquarters
Tokyo
Employees
1–10
Business Model
B2B2C
Total Funding
$16.7M
Last Round
$13.5M Series CJan 2025
Rounds
3

About

Provigate is a Japanese medtech company developing non-invasive and minimally invasive blood glucose monitoring services for diabetes prevention and management. The company focuses on glycated albumin (GA) measurement via weekly mail-in or point-of-care home testing, paired with a behavioral change app designed to help users improve glycemic control. Provigate has received support from NEDO, AMED, and the Tokyo Metropolitan Government and is conducting Phase 2 clinical trials combining weekly GA measurement with its empowerment app.

Summary

Provigate is a Healthcare company based in Tokyo, Japan. It has raised $16.7M in total across 3 rounds, most recently a $13.5M Series C round in Jan 2025. Investors include Toyoda Gosei, SPARX Group and ANRI.

Tech & App Stack

5 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CJan 2025
$13.5M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies